New York's medical office bid is a bet on regulation

The $302.2 million that put New York City fourth on CBRE's U.S. medical outpatient building investment ranking in the four quarters through the second quarter of 2026 — a 191 percent increase — is a bet on regulation as much as on the buildings changing hands.

The quarterly figures change the shape: the second quarter produced $72 million, more than triple the same period a year earlier, but $302.2 million over four quarters is roughly $75.6 million a quarter, so that headline quarter landed below the trailing window's average pace, the acceleration having come earlier in the period. Working backward from that multiple puts the year-ago second quarter under $24 million. Add Long Island and New Jersey and the four-quarter total reaches $564 million, leaving about $261.8 million outside the five boroughs by subtraction.

CBRE vice chairman Bill Hartman credits the demand side — aging populations, a high concentration of premier hospital systems, strong patient demand — and then the supply side, where strict regulations limit new construction. It is that second item that prices: where approvals gate new outpatient capacity, the existing building with a health system's name on the lease is priced off the license, and the license lives with the tenant, not with the title.

That is why the ranking deserves a colder read than a fourth-place finish invites: the Sept. 14 report on the South Broward Hospital District's $69 million purchase of a 1980s Hollywood campus made the point that for medical office sellers the real exit buyer is the health system next door — the operator whose referrals give the rent roll its value. The likeliest marginal buyers for a $564 million regional tape are systems and the credit-minded owners who trade alongside them, a narrower pool than the volume suggests.

Medical outpatient product sits oddly against the office clearing trade, where trophy towers releverage and commodity stock converts. Here the tenant carries the value rather than the building, which brings price discovery sooner and with fewer headlines: the tenant either is the health system or depends on it, a relationship straightforward to underwrite and difficult to grow.

Four quarters have run at about $75.6 million each, and if the next four hold that rate, buyers are pricing the credit behind the leases; the ceiling on rent growth is set by the same regulation that keeps competitors out.